Mexico seizes almost 47,000 faulty HIV test kits

February 1, 2017

The latest in a series of medicine scandals is hitting Mexico with the government's seizure of almost 47,000 Chinese-made HIV testing kits that it says could give false negative results.

The government's medical oversight agency says the kits "could give false negatives and put at risk the lives of patients who didn't receive ."

The agency said late Monday the kits were seized at a government medical warehouse in the Gulf coast state of Veracruz.

That's the same state where officials have accused a previous administration of supplying fake medicines for state-run hospitals. The current Veracruz governor says an inert substance was administered to children instead of a cancer drug.

Explore further: Brazil's Health Ministry delays providing dengue test kits

Related Stories

China launches crackdown on drug industry

July 17, 2013

(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

US regulators recall 10-minute Ebola test

April 23, 2015

US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.

Recommended for you

Scientists zoom in on AIDS virus hideout

March 15, 2017

French scientists said Wednesday they had found a way to pinpoint elusive white blood cells which provide a hideout for the AIDS virus in people taking anti-HIV drugs.

HIV hijacks common cells to spread infection

February 16, 2017

Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), together with collaborators in Europe, discovered that a common type of cell within the human reproductive and intestinal tracts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.